Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Biogen Pharmachem Industries Ltd (formerly Sun Techno Overseas Limited) held its 30th AGM on September 25, 2025 via video conferencing. All six resolutions were passed with effectively 100% approval (votes against ranged from just 1,126 to 7,576 out of ~250 million votes polled). The resolutions covered adoption of FY25 audited financials, re-appointment of the statutory auditor, appointment of Mr. Kelash Bunkar as Wholetime Director & CFO, appointment of Mr. Aman Patel as Independent Director, enhancement of borrowing limits under Section 180(1)(c), and approval for loans/investments/guarantees under Section 186. Only about 27.75% of outstanding shares (250.48 million of 902.6 million) participated in voting, and no promoter/promoter group shares appear to have voted. Only 35 public shareholders attended the meeting.
No material shareholder impact expected — all resolutions passed by overwhelming majority with negligible dissent. The enhanced borrowing limits and Section 186 powers give the company room to take on more debt and make investments, which could signal upcoming expansion or acquisitions but also raises leverage capacity. Low turnout and absence of promoter voting may suggest weak engagement from large holders.